ClinicalTrials.Veeva

Menu

Diabetes Mellitus Community Based Screening in Minority Populations

E

Ethnicity and Disease Community Empowerment Center

Status

Unknown

Conditions

Type II Diabetes
Diabetes Mellitus

Treatments

Behavioral: Education on risk factors for Type II Diabetes
Behavioral: Education on Type II Diabetes
Behavioral: Education on regular visits to a Primary Care Provider

Study type

Observational

Funder types

Other

Identifiers

NCT01591525
EADCEC-001

Details and patient eligibility

About

The purpose of the type II diabetes (T2D) screening study is to improve diabetes care in minority communities by identifying undiagnosed and uncontrolled T2D patients, as well as help patients without a regular primary care physician (PCP) find one within their community. These goals will be achieved first through a glucose measurement. Individuals with a high glucose measurement will be confirmed with a rapid hemoglobin A1c (HgA1c) test. The HgA1c test will tell us about the patients average blood sugar over the past 3 months, which will allow us to immediately diagnose new and uncontrolled type II diabetics. All participants will fill out a survey on healthcare seeking behaviors before glucose testing. All patients who enter the study will receive education on T2D and the value of regularly visiting their PCP, and will be provided a list of PCP currently accepting new patients within a 3 mile radius. Follow-up visits at 4 and 8 months will help us determine the success this community based screening.

The investigators hypothesis is that community based screening designed with adequate education and follow-up, and performed by qualified medical professionals will improve diabetes care in minority communities as assessed through hemoglobin A1c levels over 8 months, and in the change in the number patients who visit/obtain their PCP within the study period.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults 18 and older

Exclusion criteria

  • Type I Diabetes.
  • Women who are currently pregnant.

Trial design

100 participants in 4 patient groups

Uncontrolled Diabetic
Description:
Individuals who were previously diagnosed with Type II Diabetes, but have a HgA1C greater than 7.0%
Treatment:
Behavioral: Education on regular visits to a Primary Care Provider
Behavioral: Education on Type II Diabetes
Behavioral: Education on risk factors for Type II Diabetes
Newly diagnosed Type II Diabetic
Description:
Individuals who have never been diagnosed with Type II Diabetes, but have an HgA1c greater than 7.0%
Treatment:
Behavioral: Education on regular visits to a Primary Care Provider
Behavioral: Education on Type II Diabetes
Behavioral: Education on risk factors for Type II Diabetes
Newly diagnosised pre-diabetics
Description:
Individuals who have never been diagnosed with Type II Diabetes, but have a HgA1C of 6.0%-6.9%
Treatment:
Behavioral: Education on regular visits to a Primary Care Provider
Behavioral: Education on Type II Diabetes
Behavioral: Education on risk factors for Type II Diabetes
Controlled
Description:
Diabetic or non-diabetic individuals with RPCG of less than 130 mg/dl.
Treatment:
Behavioral: Education on regular visits to a Primary Care Provider
Behavioral: Education on risk factors for Type II Diabetes

Trial contacts and locations

1

Loading...

Central trial contact

Jean Bonnet, MD; Kelly Lamb, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems